News

Compound is developing next generation biotherapeutics with its AdNectin and AdZyme technologies. AdNectins are a superior alternative to monoclonal antibodies, and AdZymes are catalytic protein antagonists. The company’s

AN-152 is a novel cytotoxic conjugate with the potential to target cancer cells that express luteinizing hormone releasing hormones (LHRH) receptors (LHRH receptor positive tumors) and thus may

The market launch of Ypsomed’s OptiClik is a major milestone for the Switzerland-based company. The product itself is the world’s first semi-disposable pen system, containing both reusable and

The award was made under the Biotechnology Center’s Strategic Growth Loan (SGL) program, which helps promising North Carolina companies succeed in the challenging startup process. Ridge Diagnostics is

Albany Molecular Research (AMRI) expects to initiate operations in Singapore in the first quarter of 2005, with the goal of providing a full range of fee-for-service chemistry technologies,

According to the filed documents, Wyeth will negotiate with individual law firms to resolve their cases using one of two models: either an expedited pay option which requires

In a statistical meta-analysis of two placebo-controlled trials, Bextra elevated the combined incidence of heart attack and stroke three-fold in coronary artery bypass graft (CABG) surgery patients. In

The study, conducted by Dr William Nichols, a geneticist at Cincinnati Children’s Hospital Medical Center, has been published in the medical journal The Lancet, as well as studies

Telomeres are DNA sequences found at the ends of chromosomes that play a key role in controlling the life span of cells. With every cell division, telomeres get